Addimmune
Rockville, US · Founded 2023 · 1 employees on LinkedIn · 1 known investors
Find your way into Addimmune
Addimmune develops gene therapy treatments for HIV, specifically AGT103-T, a first-in-class functional cure candidate that modifies patient immune cells to recognize and eliminate HIV-infected cells. The company is based in Rockville, Maryland and targets individuals living with HIV.
Founders & leadership
BW
Barry WellsMD
Investors · 1
Competitors · 2
by search overlap
American Gene Technologies35 shared keywordsAmerican Gene Technologies develops gene therapy treatments for serious diseases including HIV, phenylketonuria, and liver cancer, using a proprietary platform approach designed to accelerate drug development and reduce costs.
World Health Organization, 202530 shared keywordsThe World Health Organization is a United Nations agency founded in 1948 that leads global health initiatives and emergency response across 194 member states. It works to expand universal health coverage, coordinate responses to health emergencies, and promote healthier lives across all life stages.
Companies competing with Addimmune for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Addimmune do?
- Addimmune develops gene therapy treatments for HIV, specifically AGT103-T, a first-in-class functional cure candidate that modifies patient immune cells to recognize and eliminate HIV-infected cells. The company is based in Rockville, Maryland and targets individuals living with HIV.
- Who are Addimmune's investors?
- Addimmune's investors include Ossian Capital.
- Where is Addimmune headquartered?
- Addimmune is headquartered in Rockville, US.